100.00% -21.55

시간 외 거래: 21.65 21.65 +

Fusion Pharmaceuticals Inc (FUSN)

Fusion Pharmaceuticals Inc 주식(FUSN)의 최신 뉴스

Fusion Pharmaceuticals Inc (FUSN)

Fusion Pharmaceuticals Inc 주식(FUSN)의 최신 뉴스

AstraZeneca to buy Fusion Pharma for $2 billion in cash - MSN

Astra to Buy Fusion Pharma in Hunt for New Cancer Treatments - MSN

Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement - Longview News-Journal

Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca - Longview News-Journal

Fusion Pharmaceuticals to Present at Upcoming Investor Conferenc - GuruFocus.com

Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GuruFocus.com

Radioligand Therapies Market to Show Immense Growth by 2034, Predicts DelveInsight | Key CompaniesCurium US, Eli Lilly, Point Biopharma, Fusion, Astrazeneca - The Malaysian Reserve

Radioligand Therapies Market to Show Immense Growth by 2034, Predicts DelveInsight | Key CompaniesCurium US, Eli Lilly, Point Biopharma, Fusion, Astrazeneca - PR Newswire UK

Radioligand Therapies Market to Show Immense Growth by 2034, Predicts DelveInsight | Key CompaniesCurium US, Eli Lilly, Point Biopharma, Fusion, Astrazeneca - PR Newswire

Fusion Pharmaceuticals (FUSN) Jumps: Stock Rises 9% - Yahoo Movies UK

Wellington Management Group LLP Acquires Shares of 744,474 Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) - Defense World

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

Insider Buying: The Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Independent Director Just Bought 370% More Shares - Yahoo New Zealand News

Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates - Yahoo New Zealand News

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Shares Acquired by Avidity Partners Management LP - MarketBeat

Superstring Capital Management LP Takes $440,000 Position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) - MarketBeat

AstraZeneca closes $2M precision med company buy - Delaware Business Times

AstraZeneca Complete Fusion Acquisition - European Pharmaceutical Manufacturer

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Stock Holdings Lifted by NEOS Investment Management LLC - Defense World

Astrazeneca completes $2.4bn acquisition of Fusion – Financial News - FinancialNews.co.uk

AstraZeneca completes acquisition of clinical-stage cancer drug company - delawarebusinessnow.com

AstraZeneca Completes $2.4B Deal To Buy Pharma Co. Fusion - Law360

AstraZeneca completes acquisition of biopharma company Fusion Pharmaceuticals - Free Malaysia Today

AstraZeneca completes Fusion Pharmaceuticals acquisition - Yahoo Finance

AstraZeneca completes acquisition of biopharma company Fusion Pharma - Yahoo Finance

Acquisition of Fusion completed - PharmiWeb.com

AstraZeneca completes Fusion Pharmaceuticals acquisition - Pharmaceutical Technology

Astrazeneca swallows up Canada-based Fusion Pharmaceuticals in £1.5bn move - Yahoo Finance UK

AstraZeneca concludes acquisition of Fusion Pharma - Medical Dialogues

AstraZeneca completes acquisition of Fusion Pharmaceuticals - DirectorsTalk Interviews

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Average Recommendation of “Hold” by Analysts - Defense World

AstraZeneca finalizes Fusion Pharmaceuticals buyoutInvesting.com ZA - Investing.com South Africa

AstraZeneca finalizes Fusion Pharmaceuticals buyout By Investing.com - Investing.com Australia

AstraZeneca finalizes Fusion Pharmaceuticals buyout - Investing.com India

AstraZeneca finalizes Fusion Pharmaceuticals buyout By Investing.com - Investing.com

AstraZeneca completes acquisition of Fusion Pharmaceuticals - Seeking Alpha

AstraZeneca finalizes Fusion Pharmaceuticals buyout By Investing.com - Investing.com UK

Acquisition of Fusion Pharmaceuticals Completed – Company AnnouncementFT.com - Financial Times

The FUSN Stock Puzzle: Unraveling Fusion Pharmaceuticals Inc’s Fluctuating Performance - The InvestChronicle

Fusion Pharmaceuticals Inc (FUSN) stock: A year of ups and downs – US Post News - US Post News

Get in on Fusion Pharmaceuticals Inc's (FUSN) buy-in window today! – Sete News - SETE News

Acquisition of Fusion Pharmaceuticals Completed - PR Newswire

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 1-Year High at $21.60 - Defense World

Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 1-Year High at $21.60 - MarketBeat

Ontario court approves AstraZeneca/Fusion acquisition plan (NASDAQ:AZN) - Seeking Alpha

Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement - Marketscreener.com

Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement – Company AnnouncementFT.com - Financial Times

Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement - PR Newswire

Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase - MarketBeat

After Plunging 14.9% in 4 Weeks, Here's Why the Trend Might Reverse for Fusion Pharmaceuticals Inc. (FUSN) - Yahoo Movies UK

Fusion Pharmaceuticals Shareholders Back Major AstraZenica Deal - TipRanks

Coming to Life: A Hamilton City Magazine feature - Brighter World

Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca - citybiz

Fusion shareholders approve AstraZeneca acquisition By Investing.com - Investing.com

Fusion shareholders give green light to AstraZeneca acquisition - Seeking Alpha

Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca – Company AnnouncementFT.com - Financial Times

Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca - PR Newswire

Critical Analysis: Aura Biosciences (NASDAQ:AURA) vs. Fusion Pharmaceuticals (NASDAQ:FUSN) - Defense World

How the (FUSN) price action is used to our Advantage - Stock Traders Daily

What Kind Of Shareholders Hold The Majority In Fusion Pharmaceuticals Inc.'s (NASDAQ:FUSN) Shares? - Yahoo Movies UK

Jump Financial LLC Invests $828,000 in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) - MarketBeat

Jump Financial LLC Invests $828000 in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) - Defense World

New York State Common Retirement Fund Invests $64000 in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) - Defense World

(FUSN) Technical Pivots with Risk Controls - Stock Traders Daily

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Brokerages - MarketBeat

Fusion Pharmaceuticals doses first subject in prostate cancer trial - Clinical Trials Arena

FUSN과 유사한 종목